Phlow Corp.

Phlow Corp. has rapidly expanded its domestic pharmaceutical development and manufacturing capabilities since its founding in 2020, focusing on building a resilient U.S.-based supply chain for essential medicines using advanced technologies such as continuous flow chemistry, AI-driven analytics, and environmentally friendly processes. The company has doubled its workforce to over 90 employees in the past year, expanded laboratory space at the Virginia Biotechnology Research Park in Richmond, VA, invested heavily in analytical capabilities including high-resolution mass spectrometry tools, and operates state-of-the-art API production facilities in Petersburg. It partners with government agencies like HHS/BARDA to secure medical countermeasures critical to national health security.